Organisation paid for research Program year 2023 Source: CMS Open Payments

CNS Research Science, Inc.

Neither a doctor nor a teaching hospital

Research payments

$530,364

196 payments

Through program year 2023, CNS Research Science, Inc. is reported as receiving $530,364 in research payments, across 196 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $2,510 1
2022 Research $18,530 4
2021 Research $26,631 14
2020 Research $40,124 41
2019 Research $442,569 136

Breakdown

Who paid Research payments · program years 2019–2023
  1. Alkermes, Inc. $528,646 164 payments
  2. Sunovion Pharmaceuticals Inc. $1,719 32 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia $275,210 13 payments
  2. A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder $81,336 53 payments
  3. A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to OLANZAPINE in Adults with Schizophrenia $59,953 8 payments
  4. A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder $42,560 14 payments
  5. A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects with Schizophrenia $32,055 27 payments
  6. Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 $24,475 32 payments
  7. A Phase 3b Extension Study of Adjunctive ALKS5461 in the Treatment of Refractory Major DepressiveDisorder $10,456 13 payments
  8. A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness $2,602 4 payments
  9. A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression $1,719 32 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record